An increase in NPY activity may be associated with cancer development via actions to promote weight gain, since overweight and obesity are related to an increased risk of cancer progression (Zhang et al., 2011). The gene discussed is NPY; the disease is obesity due to melanocortin 4 receptor deficiency.